| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bfeafa43c3761aa25b38d98de9431f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d85879bc69472ef9748215410bc5e4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20ac32057eae4fe66dd5d146b0c97f30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bcff13f8573db698307f919e6385d5c4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate |
2010-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6afa76cf5cc60a70d71fd88277fef4ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a2df654f6d11e3a523380d456d285a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f70b13a7bcac72ca75e45fb0ba70ed58 |
| publicationDate |
2012-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8143232-B2 |
| titleOfInvention |
Gene fusion targeted therapy |
| abstract |
The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer. |
| priorityDate |
2009-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |